Stratum corneum component

Stratum corneum components are not a single molecule or defined receptor but rather refer collectively to the various constituents that make up the outermost layer of the epidermis—the stratum corneum. This layer primarily consists of flattened, dead cells (corneocytes) embedded in a lipid matrix composed of ceramides, cholesterol, and free fatty acids[1][3][5][7]. The stratum corneum serves as the chief barrier against environmental insults, preventing water loss and protecting underlying tissue from mechanical stress, microbial invasion, toxins, and allergens[1][2][3][4][5][9]. Its lipid and protein elements are critical for barrier properties, and disturbances can result in skin diseases involving inflammation or increased susceptibility to infection[1][2]. "Stratum corneum components" is not a specific therapeutic target (e.g., not a single receptor, enzyme, or transporter), but the barrier properties and the components themselves are studied in dermatology and pharmacology for their roles in drug delivery, barrier dysfunction, and skin disease mechanisms[4][5][7]. Explanation: - “Stratum corneum components” does not correspond to a discrete biomolecular entity or canonical drug target, but rather describes a mixture of structural lipids (mainly ceramides, cholesterol, fatty acids), proteins (like keratin), and other molecular components that together form the functional permeability barrier of the skin[1][4][7]. - There is nothing misspelled about the term, but it is not a correct entry for a molecular drug target; it is an anatomical/structural descriptor and not classifiable as an enzyme, transporter, receptor, or similar entity. Therefore, is_incorrect is set to true. - No canonical abbreviation is used in the literature for “stratum corneum components.” - No drugs interact specifically with "stratum corneum components" as a molecular target, though many drug delivery strategies focus on traversing or modifying this barrier for better skin permeation[4][5]. - Mechanisms of action, biomarkers, and safety concerns are all not specifically applicable to this entry as it refers to a tissue composition rather than a molecular pharmacological target. If a specific component were named (e.g., "Kallikrein-5," "ceramide synthase," "filaggrin"), a canonical drug target entry could be constructed for that singular entity.

Other names

Stratum corneum constituentsEpidermal barrier componentsSC components